AGM/EGM31 Aug 2026, 06:51 pm
Aspira Pathlab & Diagnostics Ltd: Notice of 53rd AGM and Annual Report 2025-26
AI Summary
Aspira Pathlab & Diagnostics Ltd has issued a notice regarding its 53rd Annual General Meeting (AGM) and has enclosed the Annual Report for the financial year 2025-26. The report includes audited financial statements for the year ended March 31, 2026, the Board's Report, and the Auditors' Report. This information is being disseminated to shareholders via email and is also available on the company's website. The filing complies with SEBI and MCA regulations.
Key Highlights
- Notice issued for the 53rd Annual General Meeting (AGM).
- Annual Report for FY 2025-26 enclosed with the notice.
- Includes audited financial statements for the year ended March 31, 2026.
- Report and notice available on the company website.
- Compliance with SEBI and MCA circulars confirmed.
Price Impact
More from ASPIRA